All Astrazeneca articles
-
ArticleU.S. agencies get nod for using data, smart incentives in enforcement
Both the CFTC and CFPB “Nailed It” this week while corporate heavyweight General Electric found itself in more trouble.
-
ArticleMandate COVID-19 vaccines for all employees? Like everything, it’s complicated
So you want to mandate that all of your company’s employees get the coronavirus vaccine, once it’s available? Such a requirement is legal, but there are a host of considerations that might make it impractical, employment experts say.
-
ArticleQ&A: Shaping culture for the greater good at AstraZeneca
In this one-on-one, we caught up with Louise Vamvoukaki, director of sustainability education and engagement at AstraZeneca, who shared how the company overhauled its organizational culture through design of its Code of Ethics.
-
ArticleJim Massey: The life coach
As a sustainability leader and a fighter for equal access to healthcare, Jim Massey doesn’t just talk the talk; he walks the walk. “It’s about doing the right thing all the time,” he says.
-
Blog
AstraZeneca settles FCPA case with SEC for $5.5M
Biopharmaceutical-company AstraZeneca has reached a $5.5 million settlement with the SEC to settle claims that it violated the Foreign Corrupt Practices Act by making improper payments to state-controlled healthcare providers in China and Russia. Jaclyn Jaeger reports.